EcoDrugPlus

Dihydroorotate Dehydrogenase

Ensembl ID : ENSORLG00000005804
Gene Symbol: DHODH
4 Cross references
172 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSORLG00000010732
Gene Symbol: LOC105354122
3 Cross references
194 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSORLG00000013626
Gene Symbol: DPYDB
4 Cross references
211 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSORLG00000015116
Gene Symbol: DDR2
4 Cross references
204 Possible Orthologues:

Discoidin Domain-Containing Receptor 2

Ensembl ID : ENSORLG00000010857
Gene Symbol: LOC101156357
3 Cross references
190 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSORLG00000001681
Gene Symbol: DRD1B
1 Cross references
199 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSORLG00000007515
Gene Symbol: DRD2A
4 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSORLG00000009228
Gene Symbol: DRD3
4 Cross references
203 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSORLG00000019365
Gene Symbol: DRD4A
4 Cross references
165 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSORLG00000000088
Gene Symbol: DRD4B
4 Cross references
181 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSORLG00000022590
Gene Symbol: DRD5
2 Cross references
147 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase Family Member 2

Ensembl ID : ENSORLG00000000802
Gene Symbol: LOC101164324
3 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).